Laura Ruiz Martín

Laura Ruiz Martín

Auto-generated profile, based on publicly available information

Laura Ruiz Martín

Department of Neurosurgery, Complejo Asistencial Universitario de Salamanca, Salamanca, Castilla y Leon, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2020 in Brain Pathology
Verified
Journal Article
Open access
PDF file
MPMaría González‐Tablas Pimenta
María González‐Tablas Pimenta
AOAlvaro Otero-Rodríguez
Alvaro Otero-Rodríguez
DGDaniel Angel Arandia Guzman
Daniel Angel Arandia Guzman
DPDaniel Pascual‐Argente
Daniel Pascual‐Argente
LMLaura Ruíz Martín
Laura Ruíz Martín
MTMaría Dolores Tabernero
María Dolores Tabernero
The distribution and role of tumor‐infiltrating leucocytes in glioblastoma (GBM) remain largely unknown. Here, we investigated the cellular composition of 55 primary (adult) GBM samples by flow cytometry and correlated the tumor immune profile with patient features at diagnosis and outcome. GBM single‐cell suspensions were stained at diagnosis (n = 44) and recurrence following radiotherapy and chemotherapy (n = 11) with a panel of 8‐color monoclonal antibody combinations for the identification and enumeration of (GFAP+CD45−) tumor and normal astrocytic cells, infiltrating myeloid cells —i.e. microglial and blood‐derived tumor‐associated macrophages (TAM), M1‐like, and M2‐like TAM, neutrophils. and myeloid‐derived suppressor cells (MDSC)— and tumor‐infiltrating lymphocytes (TIL) —i.e. CD3+T‐cells and their TCD4+, TCD8+, TCD4−CD8−, and (CD25+CD127lo) regulatory (T‐regs) subsets, (CD19+CD20+) B‐cells, and (CD16+) NK‐cells—. Overall, GBM samples consisted of a major population (mean ± 1SD) of tumor and normal astrocytic cells (73% ± 16%) together with a significant but variable fraction of immune cells (24% ± 18%). Within myeloid cells, TAM predominated (13% ± 12%) including both microglial cells (10% ± 11%) and blood‐derived macrophages (3% ± 5%), in addition to a smaller proportion of neutrophils (5% ± 9%) and MDSC (4% ± 8%). Lymphocytes were less represented and mostly included TCD4+ (0.5% ± 0.7%) and TCD8+ cells (0.6% ± 0.7%), together with lower numbers of TCD4−CD8− T‐cells (0.2% ± 0.4%), T‐regs (0.1% ± 0.2%), B‐lymphocytes (0.1% ± 0.2%) and NK‐cells (0.05% ± 0.05%). Overall, three distinct immune profiles were identified: cases with a minor fraction of leucocytes, tumors with a predominance of TAM and neutrophils, and cases with mixed infiltration by TAM, neutrophils, and T‐lymphocytes. Untreated GBM patients with mixed myeloid and lymphoid immune infiltrates showed a significantly shorter patient overall survival versus the other two groups, in the absence of gains of the EGFR gene (p = 0.02). Here we show that immune cell infiltrates are systematically present in GBM, with highly variable levels and immune profiles. Patients with mixed myeloid and T‐lymphoid infiltrates showed a worse outcome.

9 December 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
IPIgor Paredes
Igor Paredes
ALAna Maria Castaño Leon
Ana Maria Castaño Leon
Alfonso LagaresAlfonso Lagares
Alfonso Lagares
LJLuis Jimenez-Roldan
Luis Jimenez-Roldan
APAngel Perez-Nuñez
Angel Perez-Nuñez
GJGorka Zabalo San Juan
Gorka Zabalo San Juan
Objective: To assess the effect of the first wave of the SARS-CoV-2 pandemic on the outcome of neurosurgical patients in Spain. Settings: The initial flood of COVID-19 patients overwhelmed an unprepared healthcare system. Different measures were taken to deal with this overburden. The effect of these measures on neurosurgical patients, as well as the effect of COVID-19 itself, has not been thoroughly studied. Participants: This was a multicentre, nationwide, observational retrospective study of patients who underwent any neurosurgical operation from March to July 2020. Interventions: An exploratory factorial analysis was performed to select the most relevant variables of the sample. Primary and secondary outcome measures: Univariate and multivariate analyses were performed to identify independent predictors of mortality and postoperative SARS-CoV-2 infection. Results: Sixteen hospitals registered 1677 operated patients. The overall mortality was 6.4%, and 2.9% (44 patients) suffered a perioperative SARS-CoV-2 infection. Of those infections, 24 were diagnosed postoperatively. Age (OR 1.05), perioperative SARS-CoV-2 infection (OR 4.7), community COVID-19 incidence (cases/10 5 people/week) (OR 1.006), postoperative neurological worsening (OR 5.9), postoperative need for airway support (OR 5.38), ASA grade ≥3 (OR 2.5) and preoperative GCS 3–8 (OR 2.82) were independently associated with mortality. For SARS-CoV-2 postoperative infection, screening swab test <72 hours preoperatively (OR 0.76), community COVID-19 incidence (cases/10 5 people/week) (OR 1.011), preoperative cognitive impairment (OR 2.784), postoperative sepsis (OR 3.807) and an absence of postoperative complications (OR 0.188) were independently associated. Conclusions: Perioperative SARS-CoV-2 infection in neurosurgical patients was associated with an increase in mortality by almost fivefold. Community COVID-19 incidence (cases/10 5 people/week) was a statistically independent predictor of mortality. Trial registration number: CEIM 20/217.

20 June 2023 in Neurocirugia
Verified
Journal Article
Closed access
LCL. Torres Carretero
L. Torres Carretero
LML. Cid Mendes
L. Cid Mendes
AMA. García Martín
A. García Martín
RLR. Uriel Lavín
R. Uriel Lavín
DCD.R. Rodríguez Cedeño
D.R. Rodríguez Cedeño
JEJ.M. Gonçalves Estella
J.M. Gonçalves Estella

20 June 2023 in Neurocirugia
Verified
Journal Article
Closed access
LML. Cid Mendes
L. Cid Mendes
DAD. Pascual Argente
D. Pascual Argente
DGD.á. Arandia Guzmán
D.á. Arandia Guzmán
JOJuan Carlos Roa Montes de Oca
Juan Carlos Roa Montes de Oca
LCL. Torres Carretero
L. Torres Carretero
LML. Ruiz Martín
L. Ruiz Martín

20 June 2023 in Neurocirugia
Verified
Journal Article
Closed access
RLR. Uriel Lavín
R. Uriel Lavín
DCD.R. Rodríguez Cedeño
D.R. Rodríguez Cedeño
LML. Ruiz Martín
L. Ruiz Martín
PRP.A. Garrido Ruiz
P.A. Garrido Ruiz
LCL. Torres Carretero
L. Torres Carretero
DAD. Pascual Argente
D. Pascual Argente